COMMUNIQUÉS West-GlobeNewswire

MRI Interventions and Monteris Medical Announce Collaboration to Develop Next-Generation Head Fixation Frames for Laser Ablation Neurosurgery

12/10/2018 - 14:30

IRVINE, Calif., Oct. 12, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) and Monteris Medical, Inc. today announced a collaborative co-development agreement to provide a next-generation head fixation frame [...]

Equillium Announces Pricing of Initial Public Offering

12/10/2018 - 14:25

LA JOLLA, Calif., Oct. 12, 2018 (GLOBE NEWSWIRE) -- Equillium Inc. (Nasdaq: EQ), a biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory [...]

Scythian Biosciences Applauds the UK Government’s Decision to Legalize Medical Cannabis

12/10/2018 - 14:15

Scythian’s Chief Medical Officer, The Famed Dr. Barnes, Receives National Praise for His Advocacy, Education and Tireless Leadership from Government, Media and Medical Organizations to Assist in Making This Major Event [...]

Foamix to Present Clinical Data From Study FX2017-22 at the Fall Clinical Dermatology Conference

12/10/2018 - 14:00

REHOVOT, Israel and BRIDGEWATER, N.J., Oct. 12, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and [...]

Iovance Biotherapeutics, Inc. Announces Pricing of Its Public Offering of Approximately $220 Million of Common Stock

12/10/2018 - 13:45

SAN CARLOS, Calif., Oct. 12, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (Nasdaq:IOVA) (“Iovance” or “Company”), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating [...]

Auris Medical to provide update on intranasal betahistine program on Wednesday, October 17, 2018

12/10/2018 - 13:30

Zug, Switzerland, October 12, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and mental health [...]

Emblem to supply British Columbia and Saskatchewan markets with high quality cannabis

12/10/2018 - 13:00

Emblem supply to reach four key provinces TORONTO, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF ) (“Emblem” or the "Company") today announced that its wholly-owned subsidiary, Emblem Cannabis [...]

Alliqua BioMedical Inc. and Adynxx, Inc. Announce Merger Agreement to Create NASDAQ-listed Clinical-Stage Pharmaceutical Company with a Focus on Pain and Inflammation

12/10/2018 - 13:00

LANGHORNE, Pa. and SAN FRANCISCO, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) and Adynxx, Inc., a privately held biopharmaceutical company, today announced that they have entered into a [...]

Axsome Therapeutics to Present at Upcoming Investor Conferences

12/10/2018 - 13:00

NEW YORK, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]

INSYS Therapeutics and UC San Diego’s Center for Medicinal Cannabis Research Add Anxiety in Anorexia Nervosa to Series of Collaborative Cannabidiol (CBD) Studies

12/10/2018 - 12:00

To advance the medical science of pharmaceutical cannabinoids, pioneering company has now committed to supporting seven clinical trials of its proprietary CBD oral solution PHOENIX, Oct. 12, 2018 (GLOBE NEWSWIRE) -- [...]

BeiGene Announces Updated Results from Phase 1 Clinical Trial of Zanubrutinib in Patients with Waldenström’s Macroglobulinemia

12/10/2018 - 12:00

CAMBRIDGE, Mass. and BEIJING, China, Oct. 12, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]

Mesoblast and Tasly Pharmaceutical Group Complete Transaction for Strategic Cardiovascular Partnership in China

12/10/2018 - 12:00

NEW YORK and MELBOURNE, Australia, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced completion of the transaction with Tasly Pharmaceutical Group to establish a strategic [...]

Ossur Hf : Q3 2018 Results - Conference call Thursday 25 October at 11:00 CET

12/10/2018 - 11:11

Announcement no. 60/2018 12 October 2018 Conference call on Thursday 25 October at 11:00 CET / 9:00 GMT / 5:00 EDT Össur will publish its financial results for Q3 2018 prior to market opening on Thursday 25 October. [...]

Fiasp® is effective at controlling blood sugar levels in children and adolescents living with type 1 diabetes, when compared to conventional insulin aspart

12/10/2018 - 11:01

Hyderabad, India, 12 October 2018 - For children and adolescents (1 to <18 years old) living with type 1 diabetes, Fiasp ® (an ultra-fast acting formulation of insulin aspart) could be an option to better manage [...]

GUERBET : Mise à disposition du Rapport Financier semestriel 2018

12/10/2018 - 10:58

Villepinte, le 12 octobre 2018 - Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l'imagerie médicale, annonce ce jour avoir mis à la disposition du public et déposé auprès de [...]

Rule 2.9 Announcement

12/10/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 12 October 2018 [...]

Kiadis Pharma provides regulatory and clinical update on ATIR101

12/10/2018 - 07:01

Potential CHMP opinion moved from Q4 2018 into H1 2019 Guidance for initial EU commercial launch in H2 2019 unchanged FDA meeting held under RMAT status Phase 3 study on track with over 20 open sites expected by end [...]

Veritas Pharma Attending CannX International Medical Cannabis Conference in Tel Aviv, Israel

11/10/2018 - 23:55

VANCOUVER, British Columbia, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce that its CEO Dr. Lui Franciosi and [...]

Abattis Bioceuticals Provides Update on Vaporizer Product Line

11/10/2018 - 23:16

VANCOUVER, British Columbia, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “ Company " or " Abattis ") (CSE:ATT) (OTC:ATTBF) is pleased to announce an update on our recent product line addition of [...]